Rociletinib shows good tolerability and durable activity in the phase I/II TIGER-X study Nov. 26, 2014
In vivo data for novel P. falciparum multi-antigen, multistage adenovirus vectored vaccine Nov. 25, 2014
Early results for E-7438 show response in patients with lymphoma and advanced solid tumors Nov. 25, 2014